2-(4-Cyclopropylphenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane, 95.0%, 5g

(R)-1-tert-Butyl 2-methyl 4-oxopyrrolidine-1,2-dicarboxylate, 95.0%, 250mg

2-Amino-2-(2-methoxyphenyl)ethanol, 95.0%, 250mg

Pyridine-2-sulfonylacetonitrile, 99.0%, 1g

6-(TRIFLUOROMETHOXY)QUINOLIN-3-AMINE, 95%, 250mg

3-(4-fluorophenyl)-1-phenyl-1H-pyrazole-4-carboxylic acid, 95.0%, 1g

2-{[(2-methyl-1,3-thiazol-4-yl)methyl]sulfanyl}benzoic acid, 97%, 100mg

1,1,1,3,3,3-Hexafluoro-2-propanol (HFIP) , 25mL, >=99%, for peptide synthesis

1-(5-Bromopyrimidin-2-yl)piperidine-3-carboxylic acid, 95.0%, 10g

1-Ethyl-3-methylimidazolium Acetate, 95.0%, 5g

1,2-Heptanediol, 98%, 5g

Scintillation vials 20 ml Caps made from PP with aluminium seal, borosilicate glass, 500 Piece(s)

2-[(4-Methoxy-phenylamino)-methyl]-phenol, 1g